Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer

Multiple randomized studies have shown that combination of chemotherapy and immune checkpoint inhibitors (ICIs) leads to better response rates and survival as compared to chemotherapy alone in the advanced stage of NSCLC. Data suggesting a benefit to using ICIs in the neoadjuvant therapy of patients...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Med
Main Authors: Tfayli, Arafat, Al Assaad, Majd, Fakhri, Ghina, Akel, Reem, Atwi, Hanine, Ghanem, Hady, El Karak, Fadi, Farhat, Fadi, Al Rabi, Kamal, Sfeir, Pierre, Youssef, Pierre, Mansour, Ziad, Assi, Hazem, Haidar, Mohamad, Abi Ghanem, Alain, Khalifeh, Ibrahim, Boulos, Fouad, Mahfouz, Ramy, Youssef, Bassem, Zeidan, Youssef, Bejjany, Rachelle, Khuri, Fadlo
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Clinical Cancer Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7666740/
https://ncbi.nlm.nih.gov/pubmed/32991781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3456
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker